Parvesh Kumar, MD

During his three decades of experience in leadership roles and as a researcher in academic medicine, Dr. Kumar has established a track record of building research and clinical programs. He has been awarded extensive extramural grant funding from multiple funding sources such as the National Institutes of Health (NIH), Department of Defense (DoD) and Pharma Industry. He has served as a Principal Investigator (PI) / Cod PI on several National Cancer Institute (NCI) sponsored multid institutional and multi-disciplinary national cooperative group clinical trials in lung cancer, head and neck tumors and prostate cancer. He is a pioneer in the use of concurrent docetaxel chemotherapy with radiation therapy in locally advanced high-risk prostate cancer.